Congenital Hemolytic AnemiaSymptoms, Doctors, Treatments, Advances & More
Learn About Congenital Hemolytic Anemia
View Main Condition: Anemia
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
Nirmish Shah is a Hematologist and a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Shah is currently accepting new patients.
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
John Strouse is a Hematologist and a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Strouse is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Thrombectomy, and Bone Marrow Aspiration. Dr. Strouse is board certified in American Board Of Internal Med, Hematology , American Board Of Pediatrics, Pediatric Hematology-Oncology, and American Board Of Pediatrics, General Pediatrics . Dr. Strouse is currently accepting new patients.
Jefferson Hematology - Honickman Center
Sophie Lanzkron is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lanzkron is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Lanzkron is board certified in Hematology. Dr. Lanzkron is currently accepting new patients.
Summary: This study is being done to see if the study drug, motixafortide, is safe in participants with sickle cell disease (SCD). Investigators also want to see if the drug will help the body increase the number of stem cells that can be collected for possible future transplant use. PRIMARY OBJECTIVE * To characterize the safety and tolerability of motixafortide in participants with SCD as determined by t...
Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need to collect biological samples from people with blood disorders. They also need to collect samples from healthy people.